Transrectal high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer: review of technical incidents and morbidity after 5 years of use.
Fiche publication
Date publication
juin 2010
Auteurs
Membres identifiés du Cancéropôle Est :
Dr AZEMAR Marie-Dominique
Tous les auteurs :
Ripert T, Azemar MD, Menard J, Bayoud Y, Messaoudi R, Duval F, Staerman F
Lien Pubmed
Résumé
The objective of this study was to report on technical incidents and early and late complications occurring in high-intensity focused ultrasound (HIFU) treatment of patients with localized prostate cancer. We performed a retrospective review of patients who were treated by Ablatherm at our centre. We recorded all technical incidents, treatment discontinuations and early (
Référence
Prostate Cancer Prostatic Dis. 2010 Jun;13(2):132-7